DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/mjh55q/investigation) has announced the addition of the "Investigation Report on China Tropisetron Market, 2010-2019" report to their offering.
Tropisetron, developed by Novartis, entered the market in the Netherlands in 1992 and then the Chinese market in the late 1990s. Tropisetron got administrative protection authorized by the Chinese government in Mar. 1994 after its original developer Sandoz submitted application. But it is now a generic drug for its patent expired on Sep. 22, 2001. Tropisetron develops fast into the absolute leader antiemetics after entering China with annual sales rising from CNY 41 million in 2005 to CNY 600 million in 2014 and CAGR reaching up to 34.7% during the period of 2005- 2014.
Currently, the tropisetron market in China is basically occupied by generic drugs which come from the following companies: Southwest Pharamceutical Co., Ltd, Wellso Pharmaceutical Co., Ltd, ReYoung Pharmaceutical Co., Ltd, Shandong Luoxin Pharmacy Stock Co., Ltd and Qilu Pharmaceutical Co., Ltd
Tropisetron has big profit margins and is easy to be applied to clinics. Since there are hundreds of thousands of cancer patients undergoing chemoradiotherapy, tropisetron enjoys a promising market in China.
Key Topics Covered:
1 Related Concepts of Tropisetron
2 Market Profile of Tropisetron in China
3 Survey on Sales Status of Tropisetron in China, 2010-2014
4 Survey on Market Share of Major Manufacturers of Tropisetron in China, 2010-2014
5 Survey on Dosage Forms of Tropisetron in China, 2010-2014
6 Reference Price of Tropisetron in Chinese Hospitals in 2014
7 Major Manufacturers of Tropisetron in Chinese Market, 2010-2014
8 Market Outlook of Tropisetron in China, 2015-2019
- Qilu Pharmaceutical Co., Ltd
- ReYoung Pharmaceutical Co., Ltd
- Shandong Luoxin Pharmacy Stock Co., Ltd
- Southwest Pharamceutical Co., Ltd
- Wellso Pharmaceutical Co., Ltd
For more information visit http://www.researchandmarkets.com/research/mjh55q/investigation